August 7, 2026
avatar-angus-chen
Cancer Reporter

First, STAT has put together a report with an intro from me on Cancer's Transformative Moments. It brings together a lot of our coverage on the biggest developments in oncology over the last year, from the KRAS revolution to AI applications. If you're not a STAT subscriber and don't have access to these stories, it's a great way to buy a bundle of articles and dive in.

In this week's news, scientists have developed about 1000 new cancer models comprising mostly of organoids, and published their work in two papers in Nature this week. These are essentially new cancer cell lines from human samples in three-dimensional cultures, and they're the culmination of a 10-year project called the Human Cancer Models Initiative. 3D models provide certain advantages, like being able to mimic the 3D cell microenvironment more faithfully than 2D models, and make it possible for scientists to conduct more advanced experiments in vitro.

This is an interesting new resource for cancer discovery that caught my eye, and something that looks like it might empower cancer scientists to do more sophisticated research in the future. It’s also interesting to think about this initiative setting up new groundwork for experimentation now, since the Trump administration has signaled a desire to move away from animal testing. The Human Cancer Models Initiative started when Barack Obama was president.

The social media influencer Sydney Towle also passed away from metastatic bile duct cancer on Wednesday. Towle had gained a following of over 1 million on TikTok after her diagnosis, as her social media content became a diary of a cancer patient. She became an advocate for cancer patients and survivors, walking runways for her cause, and also struggled with online detractors who claimed she was a fraud who didn’t actually have cancer. She was 26.


Adobe

STAT+ | FDA approves Replimune melanoma drug previously rejected twice

Twice-rejected drug cleared an advisory committee last week. Full approval will depend on an ongoing Phase 3 trial with results expected in 2027.

By Elaine Chen


Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was

In 2025, RFK Jr. claimed data did not support research into mRNA vaccines. The past year shows he was wrong

By Jeff Coller


STAT+ | Exemption of rare disease therapies in drug-pricing pilots would wipe out huge savings, analysis finds

Drugmakers are pressing CMS to keep ‘orphan’ therapies out of pilot programs, known as GUARD and GLOBE, to lower prices.

By John Wilkerson



Adobe

MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them

Experts reconsider how prostate cancer is diagnosed as a way to reduce unnecessary treatments. Under consideration: more MRIs, fewer biopsies.

By Annalisa Merelli


More around STAT

In other news

  • The U.S. relies on family caregivers. Millions of them are kids, New York Times
  • Pathos AI to license experimental breast cancer drug from China's Jiangsu Alphamab Biopharmaceutical, Reuters
  • Testing is underway on vaccines to intercept brewing colon cancer before it takes root, Associated Press

 
STAT